» Articles » PMID: 21350116

Tetrameric Far-red Fluorescent Protein As a Scaffold to Assemble an Octavalent Peptide Nanoprobe for Enhanced Tumor Targeting and Intracellular Uptake in Vivo

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2011 Feb 26
PMID 21350116
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Relatively weak tumor affinities and short retention time in vivo hinder the application of targeting peptides in tumor molecular imaging. Multivalent strategies based on various scaffolds have been utilized to improve the ability of peptide-receptor binding or extend the clearance time of peptide-based probes. Here, we use a tetrameric far-red fluorescent protein (tfRFP) as a scaffold to create a self-assembled octavalent peptide fluorescent nanoprobe (Octa-FNP) using a genetic engineering approach. The multiligand connecting, fluorophore labeling and nanostructure formation of Octa-FNP were performed in one step. In vitro studies showed Octa-FNP is a 10-nm fluorescent probe with excellent serum stability. Cellular uptake of Octa-FNP by human nasopharyngeal cancer 5-8F cells is 15-fold of tetravalent probe, ∼80-fold of monovalent probe and ∼600-fold of nulvalent tfRFP. In vivo enhanced tumor targeting and intracellular uptake of Octa-FNP were confirmed using optical imaging and Western blot analysis. It achieved extremely high contrast of Octa-FNP signal between tumor tissue and normal organs, especially seldom Octa-FNP detected in liver and spleen. Owing to easy preparation, precise structural and functional control, and multivalent effect, Octa-FNP provides a powerful tool for tumor optical molecular imaging and evaluating the targeting ability of numerous peptides in vivo.

Citing Articles

Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles.

Dai Y, Yu X, Leng Y, Peng X, Wang J, Zhao Y J Nanobiotechnology. 2023; 21(1):245.

PMID: 37528426 PMC: 10391974. DOI: 10.1186/s12951-023-02026-7.


Precision Killing of M2 Macrophages with Phage-Displayed Peptide-Photosensitizer Conjugates.

Sioud M, Zhang Q Cancers (Basel). 2023; 15(7).

PMID: 37046671 PMC: 10093000. DOI: 10.3390/cancers15072009.


Fully synthetic macromolecular prodrug chemotherapeutics with EGFR targeting and controlled camptothecin release kinetics.

Freeman H, Srinivasan S, Das D, Stayton P, Convertine A Polym Chem. 2023; 9(42):5224-5233.

PMID: 36660314 PMC: 9847574. DOI: 10.1039/c8py01047a.


Intravital molecular imaging reveals that ROS-caspase-3-GSDME-induced cell punching enhances humoral immunotherapy targeting intracellular tumor antigens.

Dai B, Zhang R, Qi S, Liu L, Zhang X, Deng D Theranostics. 2022; 12(17):7603-7623.

PMID: 36438480 PMC: 9691348. DOI: 10.7150/thno.75966.


Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery.

Liu N, Yang C, Liang X, Cao K, Xie J, Luo Q J Nanobiotechnology. 2022; 20(1):439.

PMID: 36207740 PMC: 9547428. DOI: 10.1186/s12951-022-01642-z.